3SBio Inc. (Nasdaq: SSRX) and Isotechnika Pharma Inc. today announced the signing of a development and commercialization agreement for voclosporin ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE